Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer.

Pirone JR, D'Arcy M, Stewart DA, Hines WC, Johnson M, Gould MN, Yaswen P, Jerry DJ, Smith Schneider S, Troester MA.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1735-44. doi: 10.1158/1055-9965.EPI-12-0451.

2.

Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression.

Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG, Nevins JR, Potti A, Blackwell KL.

J Clin Oncol. 2008 Jul 10;26(20):3324-30. doi: 10.1200/JCO.2007.14.2471. Erratum in: J Clin Oncol. 2011 Sep 20;29(27):3721.

PMID:
18612148
3.

Second primary breast cancer occurrence according to hormone receptor status.

Kurian AW, McClure LA, John EM, Horn-Ross PL, Ford JM, Clarke CA.

J Natl Cancer Inst. 2009 Aug 5;101(15):1058-65. doi: 10.1093/jnci/djp181.

4.

Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.

Azim HA Jr, Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, Haibe-Kains B, Piccart MJ, Sotiriou C, Loi S.

Clin Cancer Res. 2012 Mar 1;18(5):1341-51. doi: 10.1158/1078-0432.CCR-11-2599.

5.

Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

Breast Cancer Res. 2007;9(5):R59.

6.

WWOX--the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.

Płuciennik E, Kusińska R, Potemski P, Kubiak R, Kordek R, Bednarek AK.

Eur J Surg Oncol. 2006 Mar;32(2):153-7.

PMID:
16360296
7.

A gene transcription signature of obesity in breast cancer.

Creighton CJ, Sada YH, Zhang Y, Tsimelzon A, Wong H, Dave B, Landis MD, Bear HD, Rodriguez A, Chang JC.

Breast Cancer Res Treat. 2012 Apr;132(3):993-1000. doi: 10.1007/s10549-011-1595-y.

PMID:
21750966
8.

Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles.

Tchou J, Kossenkov AV, Chang L, Satija C, Herlyn M, Showe LC, Puré E.

BMC Med Genomics. 2012 Sep 6;5:39. doi: 10.1186/1755-8794-5-39.

9.

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.

Jönsson G, Staaf J, Vallon-Christersson J, Ringnér M, Holm K, Hegardt C, Gunnarsson H, Fagerholm R, Strand C, Agnarsson BA, Kilpivaara O, Luts L, Heikkilä P, Aittomäki K, Blomqvist C, Loman N, Malmström P, Olsson H, Johannsson OT, Arason A, Nevanlinna H, Barkardottir RB, Borg A.

Breast Cancer Res. 2010;12(3):R42. doi: 10.1186/bcr2596.

10.
11.
12.

The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer.

Orgéas CC, Hall P, Rosenberg LU, Czene K.

Breast Cancer Res. 2008;10(6):R107. doi: 10.1186/bcr2212.

13.

LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.

Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.

Anticancer Res. 2004 Jul-Aug;24(4):2391-400.

14.

[Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].

Zuo WS, Wei L, Wang XW, Wang YS, Yu ZY.

Ai Zheng. 2004 Nov;23(11 Suppl):1418-22. Chinese.

PMID:
15566648
15.

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.

Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL.

BMC Genomics. 2006 May 26;7:127.

16.

A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females.

García N, Salamanca F, Astudillo-de la Vega H, Curiel-Quesada E, Alvarado I, Peñaloza R, Arenas D.

BMC Cancer. 2005 Aug 1;5:93.

17.

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications.

Muranen TA, Greco D, Fagerholm R, Kilpivaara O, Kämpjärvi K, Aittomäki K, Blomqvist C, Heikkilä P, Borg A, Nevanlinna H.

Breast Cancer Res. 2011 Sep 20;13(5):R90. doi: 10.1186/bcr3015.

18.

Cancer following breast reduction surgery in Denmark.

Boice JD Jr, Friis S, McLaughlin JK, Mellemkjaer L, Blot WJ, Fraumeni JF Jr, Olsen JH.

Cancer Causes Control. 1997 Mar;8(2):253-8.

PMID:
9134250
19.

Evaluation of biological pathways involved in chemotherapy response in breast cancer.

Tordai A, Wang J, Andre F, Liedtke C, Yan K, Sotiriou C, Hortobagyi GN, Symmans WF, Pusztai L.

Breast Cancer Res. 2008;10(2):R37. doi: 10.1186/bcr2088.

20.

Poor outcome of hormone receptor-positive breast cancer at very young age is due to tamoxifen resistance: nationwide survival data in Korea--a report from the Korean Breast Cancer Society.

Ahn SH, Son BH, Kim SW, Kim SI, Jeong J, Ko SS, Han W; Korean Breast Cancer Society..

J Clin Oncol. 2007 Jun 10;25(17):2360-8.

PMID:
17515570
Items per page

Supplemental Content

Support Center